Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 136 entries
Sorted by: Best Match Show Resources per page
The INCLUDE study: INtegrating and improving Care for patients with infLammatory rheUmatological DisordErs in the community; identifying multimorbidity: Protocol for a pilot randomized controlled trial.

Journal of comorbidity

Hider SL, Bucknall M, Cooke K, Cooke K, Finney AG, Goddin D, Healey EL, Hennings S, Herron D, Jinks C, Lewis M, Machin A, Mallen C, Wathall S, Chew-Graham CA.
PMID: 30191145
J Comorb. 2018 Aug 02;8(1):2235042X18792373. doi: 10.1177/2235042X18792373. eCollection 2018.

BACKGROUND: Patients with inflammatory rheumatic conditions such as rheumatoid arthritis, polymyalgia rheumatica and ankylosing spondylitis are at increased risk of common comorbidities such as cardiovascular disease, osteoporosis and anxiety and depression which lead to increased morbidity and mortality. These...

Cite
Hider SL, Bucknall M, Cooke K, et al. The INCLUDE study: INtegrating and improving Care for patients with infLammatory rheUmatological DisordErs in the community; identifying multimorbidity: Protocol for a pilot randomized controlled trial. J Comorb. 2018;8(1):2235042X18792373doi: 10.1177/2235042X18792373.
Hider, S. L., Bucknall, M., Cooke, K., Cooke, K., Finney, A. G., Goddin, D., Healey, E. L., Hennings, S., Herron, D., Jinks, C., Lewis, M., Machin, A., Mallen, C., Wathall, S., & Chew-Graham, C. A. (2018). The INCLUDE study: INtegrating and improving Care for patients with infLammatory rheUmatological DisordErs in the community; identifying multimorbidity: Protocol for a pilot randomized controlled trial. Journal of comorbidity, 8(1), 2235042X18792373. https://doi.org/10.1177/2235042X18792373
Hider, Samantha L, et al. "The INCLUDE study: INtegrating and improving Care for patients with infLammatory rheUmatological DisordErs in the community; identifying multimorbidity: Protocol for a pilot randomized controlled trial." Journal of comorbidity vol. 8,1 (2018): 2235042X18792373. doi: https://doi.org/10.1177/2235042X18792373
Hider SL, Bucknall M, Cooke K, Cooke K, Finney AG, Goddin D, Healey EL, Hennings S, Herron D, Jinks C, Lewis M, Machin A, Mallen C, Wathall S, Chew-Graham CA. The INCLUDE study: INtegrating and improving Care for patients with infLammatory rheUmatological DisordErs in the community; identifying multimorbidity: Protocol for a pilot randomized controlled trial. J Comorb. 2018 Aug 02;8(1):2235042X18792373. doi: 10.1177/2235042X18792373. eCollection 2018. PMID: 30191145; PMCID: PMC6088485.
Copy Download .nbib Format: NLM
Histological and Gross Evaluation through Second-Look Arthroscopy of Osteochondral Lesions of the Talus after Failed Treatment with Particulated Juvenile Cartilage: A Case Series.

Journal of orthopaedic case reports

Tan EW, Finney FT, Maccario C, Talusan PG, Zhang Z, Schon LC.
PMID: 30167418
J Orthop Case Rep. 2018 Mar-Apr;8(2):69-73. doi: 10.13107/jocr.2250-0685.1056.

INTRODUCTION: The treatment of osteochondral lesions of the talus (OLTs) recalcitrant to non-surgical interventions is challenging. Particulated juvenile cartilage allograft transplantation (PJCAT) has become a viable treatment option, obviating the need for an osteotomy or second-stage surgery and eliminating...

Cite
Tan EW, Finney FT, Maccario C, et al. Histological and Gross Evaluation through Second-Look Arthroscopy of Osteochondral Lesions of the Talus after Failed Treatment with Particulated Juvenile Cartilage: A Case Series. J Orthop Case Rep. 2018;8(2):69-73doi: 10.13107/jocr.2250-0685.1056.
Tan, E. W., Finney, F. T., Maccario, C., Talusan, P. G., Zhang, Z., & Schon, L. C. (2018). Histological and Gross Evaluation through Second-Look Arthroscopy of Osteochondral Lesions of the Talus after Failed Treatment with Particulated Juvenile Cartilage: A Case Series. Journal of orthopaedic case reports, 8(2), 69-73. https://doi.org/10.13107/jocr.2250-0685.1056
Tan, Eric W, et al. "Histological and Gross Evaluation through Second-Look Arthroscopy of Osteochondral Lesions of the Talus after Failed Treatment with Particulated Juvenile Cartilage: A Case Series." Journal of orthopaedic case reports vol. 8,2 (2018): 69-73. doi: https://doi.org/10.13107/jocr.2250-0685.1056
Tan EW, Finney FT, Maccario C, Talusan PG, Zhang Z, Schon LC. Histological and Gross Evaluation through Second-Look Arthroscopy of Osteochondral Lesions of the Talus after Failed Treatment with Particulated Juvenile Cartilage: A Case Series. J Orthop Case Rep. 2018 Mar-Apr;8(2):69-73. doi: 10.13107/jocr.2250-0685.1056. PMID: 30167418; PMCID: PMC6114197.
Copy Download .nbib Format: NLM
Heterospin biradicals provide insight into molecular conductance and rectification.

Chemical science

Kirk ML, Shultz DA, Zhang J, Dangi R, Ingersol L, Yang J, Finney NS, Sommer RD, Wojtas L.
PMID: 28970920
Chem Sci. 2017 Aug 01;8(8):5408-5415. doi: 10.1039/c7sc00073a. Epub 2017 Jun 01.

The correlation of electron transfer with molecular conductance (

Cite
Kirk ML, Shultz DA, Zhang J, et al. Heterospin biradicals provide insight into molecular conductance and rectification. Chem Sci. 2017;8(8):5408-5415doi: 10.1039/c7sc00073a.
Kirk, M. L., Shultz, D. A., Zhang, J., Dangi, R., Ingersol, L., Yang, J., Finney, N. S., Sommer, R. D., & Wojtas, L. (2017). Heterospin biradicals provide insight into molecular conductance and rectification. Chemical science, 8(8), 5408-5415. https://doi.org/10.1039/c7sc00073a
Kirk, Martin L, et al. "Heterospin biradicals provide insight into molecular conductance and rectification." Chemical science vol. 8,8 (2017): 5408-5415. doi: https://doi.org/10.1039/c7sc00073a
Kirk ML, Shultz DA, Zhang J, Dangi R, Ingersol L, Yang J, Finney NS, Sommer RD, Wojtas L. Heterospin biradicals provide insight into molecular conductance and rectification. Chem Sci. 2017 Aug 01;8(8):5408-5415. doi: 10.1039/c7sc00073a. Epub 2017 Jun 01. PMID: 28970920; PMCID: PMC5609533.
Copy Download .nbib Format: NLM
Applying the Z method to estimate temperatures of melting in structure II clathrate hydrates.

Physical chemistry chemical physics : PCCP

Finney AR, Rodger PM.
PMID: 21993402
Phys Chem Chem Phys. 2011 Nov 28;13(44):19979-87. doi: 10.1039/c1cp21919g. Epub 2011 Oct 13.

Equilibrium melting temperatures for structure II THF hydrate and argon/xenon (Ar/Xe) binary hydrate have been calculated using molecular dynamics using two melting techniques, namely the Z method [Belonoshko et al., Phys. Rev. B, 2006, 73, 012201] (applied for the...

Cite
Finney AR, Rodger PM. Applying the Z method to estimate temperatures of melting in structure II clathrate hydrates. Phys Chem Chem Phys. 2011;13(44):19979-87doi: 10.1039/c1cp21919g.
Finney, A. R., & Rodger, P. M. (2011). Applying the Z method to estimate temperatures of melting in structure II clathrate hydrates. Physical chemistry chemical physics : PCCP, 13(44), 19979-87. https://doi.org/10.1039/c1cp21919g
Finney, Aaron R, and Rodger, P Mark. "Applying the Z method to estimate temperatures of melting in structure II clathrate hydrates." Physical chemistry chemical physics : PCCP vol. 13,44 (2011): 19979-87. doi: https://doi.org/10.1039/c1cp21919g
Finney AR, Rodger PM. Applying the Z method to estimate temperatures of melting in structure II clathrate hydrates. Phys Chem Chem Phys. 2011 Nov 28;13(44):19979-87. doi: 10.1039/c1cp21919g. Epub 2011 Oct 13. PMID: 21993402.
Copy Download .nbib Format: NLM
Guidance Molecules in Vascular Smooth Muscle.

Frontiers in physiology

Finney AC, Orr AW.
PMID: 30283356
Front Physiol. 2018 Sep 19;9:1311. doi: 10.3389/fphys.2018.01311. eCollection 2018.

Several highly conserved families of guidance molecules, including ephrins, Semaphorins, Netrins, and Slits, play conserved and distinct roles in tissue remodeling during tissue patterning and disease pathogenesis. Primarily, these guidance molecules function as either secreted or surface-bound ligands that...

Cite
Finney AC, Orr AW. Guidance Molecules in Vascular Smooth Muscle. Front Physiol. 2018;9:1311doi: 10.3389/fphys.2018.01311.
Finney, A. C., & Orr, A. W. (2018). Guidance Molecules in Vascular Smooth Muscle. Frontiers in physiology, 91311. https://doi.org/10.3389/fphys.2018.01311
Finney, Alexandra Christine, and Orr, Anthony Wayne. "Guidance Molecules in Vascular Smooth Muscle." Frontiers in physiology vol. 9 (2018): 1311. doi: https://doi.org/10.3389/fphys.2018.01311
Finney AC, Orr AW. Guidance Molecules in Vascular Smooth Muscle. Front Physiol. 2018 Sep 19;9:1311. doi: 10.3389/fphys.2018.01311. eCollection 2018. PMID: 30283356; PMCID: PMC6157320.
Copy Download .nbib Format: NLM
Recurrent Radiation Recall Mucosal Toxicity of the Upper Aerodigestive Tract: A Case Report.

Advances in radiation oncology

McGrath LA, Martenson JA, Finley RR.
PMID: 31011666
Adv Radiat Oncol. 2018 Nov 14;4(2):229-232. doi: 10.1016/j.adro.2018.11.002. eCollection 2019.

No abstract available.

Cite
McGrath LA, Martenson JA, Finley RR. Recurrent Radiation Recall Mucosal Toxicity of the Upper Aerodigestive Tract: A Case Report. Adv Radiat Oncol. 2018;4(2):229-232doi: 10.1016/j.adro.2018.11.002.
McGrath, L. A., Martenson, J. A., & Finley, R. R. (2019). Recurrent Radiation Recall Mucosal Toxicity of the Upper Aerodigestive Tract: A Case Report. Advances in radiation oncology, 4(2), 229-232. https://doi.org/10.1016/j.adro.2018.11.002
McGrath, Laura A, et al. "Recurrent Radiation Recall Mucosal Toxicity of the Upper Aerodigestive Tract: A Case Report." Advances in radiation oncology vol. 4,2 (2019): 229-232. doi: https://doi.org/10.1016/j.adro.2018.11.002
McGrath LA, Martenson JA, Finley RR. Recurrent Radiation Recall Mucosal Toxicity of the Upper Aerodigestive Tract: A Case Report. Adv Radiat Oncol. 2018 Nov 14;4(2):229-232. doi: 10.1016/j.adro.2018.11.002. eCollection 2019. PMID: 31011666; PMCID: PMC6460096.
Copy Download .nbib Format: NLM
The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder.

Human mutation

Kumble S, Levy AM, Punetha J, Gao H, Mew NA, Anyane-Yeboa K, Benke PJ, Berger SM, Bjerglund L, Campos-Xavier B, Ciliberto M, Cohen JS, Comi AM, Curry C, Damaj L, Denommé-Pichon AS, Emrick L, Faivre L, Fasano MB, Fiévet A, Finkel RS, García-Miñaúr S, Gerard A, Gomez-Puertas P, Guillen Sacoto MJ, Hoffman TL, Howard L, Iglesias AD, Izumi K, Larson A, Leiber A, Lozano R, Marcos-Alcalde I, Mintz CS, Mullegama SV, Møller RS, Odent S, Oppermann H, Ostergaard E, Pacio-Míguez M, Palomares-Bralo M, Parikh S, Paulson AM, Platzer K, Posey JE, Potocki L, Revah-Politi A, Rio M, Ritter AL, Robinson S, Rosenfeld JA, Santos-Simarro F, Sousa SB, Network UD, Wéber M, Xie Y, Chung WK, Brown NJ, Tümer Z.
PMID: 34859529
Hum Mutat. 2021 Dec 02; doi: 10.1002/humu.24308. Epub 2021 Dec 02.

De novo variants in QRICH1 (Glutamine-rich protein 1) has recently been reported in 11 individuals with intellectual disability. The function of QRICH1 is largely unknown but it is likely to play a key role in the unfolded response of...

Cite
Kumble S, Levy AM, Punetha J, et al. The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder. Hum Mutat. 2021;doi: 10.1002/humu.24308.
Kumble, S., Levy, A. M., Punetha, J., Gao, H., Mew, N. A., Anyane-Yeboa, K., Benke, P. J., Berger, S. M., Bjerglund, L., Campos-Xavier, B., Ciliberto, M., Cohen, J. S., Comi, A. M., Curry, C., Damaj, L., Denommé-Pichon, A. S., Emrick, L., Faivre, L., Fasano, M. B., Fiévet, A., Finkel, R. S., García-Miñaúr, S., Gerard, A., Gomez-Puertas, P., Guillen Sacoto, M. J., Hoffman, T. L., Howard, L., Iglesias, A. D., Izumi, K., Larson, A., Leiber, A., Lozano, R., Marcos-Alcalde, I., Mintz, C. S., Mullegama, S. V., Møller, R. S., Odent, S., Oppermann, H., Ostergaard, E., Pacio-Míguez, M., Palomares-Bralo, M., Parikh, S., Paulson, A. M., Platzer, K., Posey, J. E., Potocki, L., Revah-Politi, A., Rio, M., Ritter, A. L., Robinson, S., Rosenfeld, J. A., Santos-Simarro, F., Sousa, S. B., Network, U. D., Wéber, M., Xie, Y., Chung, W. K., Brown, N. J., & Tümer, Z. (2021). The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder. Human mutation, . https://doi.org/10.1002/humu.24308
Kumble, Smitha, et al. "The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder." Human mutation vol. (2021). doi: https://doi.org/10.1002/humu.24308
Kumble S, Levy AM, Punetha J, Gao H, Mew NA, Anyane-Yeboa K, Benke PJ, Berger SM, Bjerglund L, Campos-Xavier B, Ciliberto M, Cohen JS, Comi AM, Curry C, Damaj L, Denommé-Pichon AS, Emrick L, Faivre L, Fasano MB, Fiévet A, Finkel RS, García-Miñaúr S, Gerard A, Gomez-Puertas P, Guillen Sacoto MJ, Hoffman TL, Howard L, Iglesias AD, Izumi K, Larson A, Leiber A, Lozano R, Marcos-Alcalde I, Mintz CS, Mullegama SV, Møller RS, Odent S, Oppermann H, Ostergaard E, Pacio-Míguez M, Palomares-Bralo M, Parikh S, Paulson AM, Platzer K, Posey JE, Potocki L, Revah-Politi A, Rio M, Ritter AL, Robinson S, Rosenfeld JA, Santos-Simarro F, Sousa SB, Network UD, Wéber M, Xie Y, Chung WK, Brown NJ, Tümer Z. The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder. Hum Mutat. 2021 Dec 02; doi: 10.1002/humu.24308. Epub 2021 Dec 02. PMID: 34859529.
Copy Download .nbib Format: NLM
Development, spread and impact of primary care and musculoskeletal communities of practice to assist rapid translation of evidence into practice.

Musculoskeletal care

Stevenson K, Sarigiovannis P, Finney AG, Cottrell E, Lewis R, Edwards JJ, Hadley-Barrows T, Thomson K, Reay H, Dziedzic KS.
PMID: 33755287
Musculoskeletal Care. 2021 Dec;19(4):564-569. doi: 10.1002/msc.1552. Epub 2021 Mar 23.

BACKGROUND: Embedding research into practice is challenging. Barriers include: a shortage of time, lack of understanding of the evidence and a poor support in the clinical setting. A community of practice (CoP) model has been used to address these...

Cite
Stevenson K, Sarigiovannis P, Finney AG, et al. Development, spread and impact of primary care and musculoskeletal communities of practice to assist rapid translation of evidence into practice. Musculoskeletal Care. 2021;19(4):564-569doi: 10.1002/msc.1552.
Stevenson, K., Sarigiovannis, P., Finney, A. G., Cottrell, E., Lewis, R., Edwards, J. J., Hadley-Barrows, T., Thomson, K., Reay, H., & Dziedzic, K. S. (2021). Development, spread and impact of primary care and musculoskeletal communities of practice to assist rapid translation of evidence into practice. Musculoskeletal care, 19(4), 564-569. https://doi.org/10.1002/msc.1552
Stevenson, Kay, et al. "Development, spread and impact of primary care and musculoskeletal communities of practice to assist rapid translation of evidence into practice." Musculoskeletal care vol. 19,4 (2021): 564-569. doi: https://doi.org/10.1002/msc.1552
Stevenson K, Sarigiovannis P, Finney AG, Cottrell E, Lewis R, Edwards JJ, Hadley-Barrows T, Thomson K, Reay H, Dziedzic KS. Development, spread and impact of primary care and musculoskeletal communities of practice to assist rapid translation of evidence into practice. Musculoskeletal Care. 2021 Dec;19(4):564-569. doi: 10.1002/msc.1552. Epub 2021 Mar 23. PMID: 33755287.
Copy Download .nbib Format: NLM
Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy.

Drug safety

Day JW, Mendell JR, Mercuri E, Finkel RS, Strauss KA, Kleyn A, Tauscher-Wisniewski S, Tukov FF, Reyna SP, Chand DH.
PMID: 34383289
Drug Saf. 2021 Oct;44(10):1109-1119. doi: 10.1007/s40264-021-01107-6. Epub 2021 Aug 12.

INTRODUCTION: This is the first description of safety data for intravenous onasemnogene abeparvovec, the only approved systemically administered gene-replacement therapy for spinal muscular atrophy.OBJECTIVE: We comprehensively assessed the safety of intravenous onasemnogene abeparvovec from preclinical studies, clinical studies, and...

Cite
Day JW, Mendell JR, Mercuri E, et al. Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy. Drug Saf. 2021;44(10):1109-1119doi: 10.1007/s40264-021-01107-6.
Day, J. W., Mendell, J. R., Mercuri, E., Finkel, R. S., Strauss, K. A., Kleyn, A., Tauscher-Wisniewski, S., Tukov, F. F., Reyna, S. P., & Chand, D. H. (2021). Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy. Drug safety, 44(10), 1109-1119. https://doi.org/10.1007/s40264-021-01107-6
Day, John W, et al. "Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy." Drug safety vol. 44,10 (2021): 1109-1119. doi: https://doi.org/10.1007/s40264-021-01107-6
Day JW, Mendell JR, Mercuri E, Finkel RS, Strauss KA, Kleyn A, Tauscher-Wisniewski S, Tukov FF, Reyna SP, Chand DH. Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy. Drug Saf. 2021 Oct;44(10):1109-1119. doi: 10.1007/s40264-021-01107-6. Epub 2021 Aug 12. PMID: 34383289; PMCID: PMC8473343.
Copy Download .nbib Format: NLM
Implementation and Evaluation of Gradient Strip Antimicrobial Susceptibility Testing in US Public Health Laboratories to Respond to Resistant Gonorrhea.

Sexually transmitted diseases

Raphael BH, Pham CD, Sharpe S, Mauk K, Harvey A, Khubbar M, Triplett L, Soge OO, Denny M, Palavecino EL, Finney R, Olsen A, Carlson J, St Cyr SB, Schlanger K, Kersh EN.
PMID: 34433794
Sex Transm Dis. 2021 Dec 01;48(12):S157-S160. doi: 10.1097/OLQ.0000000000001535.

BACKGROUND: Gradient strip antimicrobial susceptibility testing using Etest is conducted by local public health jurisdictions participating in the Strengthening the US Response to Resistant Gonorrhea (SURRG) program to inform public health responses to resistant gonorrhea. Proficiency testing results across...

Cite
Raphael BH, Pham CD, Sharpe S, et al. Implementation and Evaluation of Gradient Strip Antimicrobial Susceptibility Testing in US Public Health Laboratories to Respond to Resistant Gonorrhea. Sex Transm Dis. 2021;48(12):S157-S160doi: 10.1097/OLQ.0000000000001535.
Raphael, B. H., Pham, C. D., Sharpe, S., Mauk, K., Harvey, A., Khubbar, M., Triplett, L., Soge, O. O., Denny, M., Palavecino, E. L., Finney, R., Olsen, A., Carlson, J., St Cyr, S. B., Schlanger, K., Kersh, E. N. (2021). Implementation and Evaluation of Gradient Strip Antimicrobial Susceptibility Testing in US Public Health Laboratories to Respond to Resistant Gonorrhea. Sexually transmitted diseases, 48(12), S157-S160. https://doi.org/10.1097/OLQ.0000000000001535
Raphael, Brian H, et al. "Implementation and Evaluation of Gradient Strip Antimicrobial Susceptibility Testing in US Public Health Laboratories to Respond to Resistant Gonorrhea." Sexually transmitted diseases vol. 48,12 (2021): S157-S160. doi: https://doi.org/10.1097/OLQ.0000000000001535
Raphael BH, Pham CD, Sharpe S, Mauk K, Harvey A, Khubbar M, Triplett L, Soge OO, Denny M, Palavecino EL, Finney R, Olsen A, Carlson J, St Cyr SB, Schlanger K, Kersh EN. Implementation and Evaluation of Gradient Strip Antimicrobial Susceptibility Testing in US Public Health Laboratories to Respond to Resistant Gonorrhea. Sex Transm Dis. 2021 Dec 01;48(12):S157-S160. doi: 10.1097/OLQ.0000000000001535. PMID: 34433794.
Copy Download .nbib Format: NLM
CASPT2 molecular geometries of Fe(II) spin-crossover complexes.

Physical chemistry chemical physics : PCCP

Finney BA, Chowdhury SR, Kirkvold C, Vlaisavljevich B.
PMID: 34981806
Phys Chem Chem Phys. 2022 Jan 04; doi: 10.1039/d1cp04885f. Epub 2022 Jan 04.

Using fully internally contracted (FIC)-CASPT2 analytical gradients, geometry optimizations of spin-crossover complexes are reported. This approach is tested on a series of Fe(II) complexes with different sizes, ranging from 13 to 61 atoms. A combination of active space and...

Cite
Finney BA, Chowdhury SR, Kirkvold C, et al. CASPT2 molecular geometries of Fe(II) spin-crossover complexes. Phys Chem Chem Phys. 2022;doi: 10.1039/d1cp04885f.
Finney, B. A., Chowdhury, S. R., Kirkvold, C., & Vlaisavljevich, B. (2022). CASPT2 molecular geometries of Fe(II) spin-crossover complexes. Physical chemistry chemical physics : PCCP, . https://doi.org/10.1039/d1cp04885f
Finney, Brian A, et al. "CASPT2 molecular geometries of Fe(II) spin-crossover complexes." Physical chemistry chemical physics : PCCP vol. (2022). doi: https://doi.org/10.1039/d1cp04885f
Finney BA, Chowdhury SR, Kirkvold C, Vlaisavljevich B. CASPT2 molecular geometries of Fe(II) spin-crossover complexes. Phys Chem Chem Phys. 2022 Jan 04; doi: 10.1039/d1cp04885f. Epub 2022 Jan 04. PMID: 34981806.
Copy Download .nbib Format: NLM
Transrectal Ultrasound MRI-Fusion Biopsy of Perirectal Mass.

Journal of endourology case reports

Li V, Mclemore E, Attaluri V, Parker R, Finley DS.
PMID: 33457675
J Endourol Case Rep. 2020 Dec 29;6(4):366-369. doi: 10.1089/cren.2020.0016. eCollection 2020.

This case report describes the novel use of ultrasound-guided MRI-fusion biopsy to sample an extraluminal perirectal mass. This is a 64-year-old man with a history of pT3N2b mucinous adenocarcinoma of the right colon with metastatic disease to the mesocolic...

Cite
Li V, Mclemore E, Attaluri V, et al. Transrectal Ultrasound MRI-Fusion Biopsy of Perirectal Mass. J Endourol Case Rep. 2020;6(4):366-369doi: 10.1089/cren.2020.0016.
Li, V., Mclemore, E., Attaluri, V., Parker, R., & Finley, D. S. (2020). Transrectal Ultrasound MRI-Fusion Biopsy of Perirectal Mass. Journal of endourology case reports, 6(4), 366-369. https://doi.org/10.1089/cren.2020.0016
Li, Virginia, et al. "Transrectal Ultrasound MRI-Fusion Biopsy of Perirectal Mass." Journal of endourology case reports vol. 6,4 (2020): 366-369. doi: https://doi.org/10.1089/cren.2020.0016
Li V, Mclemore E, Attaluri V, Parker R, Finley DS. Transrectal Ultrasound MRI-Fusion Biopsy of Perirectal Mass. J Endourol Case Rep. 2020 Dec 29;6(4):366-369. doi: 10.1089/cren.2020.0016. eCollection 2020. PMID: 33457675; PMCID: PMC7803207.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 136 entries